LYRM4 and cancer: Moreover, in the sex, weight, race, individual cancer stage, tumour grade, nodal metastasis, and TP53 mutation status subgroup analyses, the expression of LYRM4 mRNA was also significantly higher in LIHC patients (Fig. 2).